Literature DB >> 35998012

Hepatocellular Carcinoma in Mongolia Delineates Unique Molecular Traits and a Mutational Signature Associated with Environmental Agents.

Laura Torrens1,2, Marc Puigvehí1,3, Miguel Torres-Martín1,2, Huan Wang4, Miho Maeda1, Philipp K Haber1, Thais Leonel5, Mireia García-López5, Roger Esteban-Fabró1,2, Wei Qiang Leow1,6, Carla Montironi1,2, Sara Torrecilla2, Ajay Ramakrishnan Varadarajan4, Patricia Taik4, Genís Campreciós1,5, Chinbold Enkhbold7, Erdenebileg Taivanbaatar8, Amankyeldi Yerbolat8, Augusto Villanueva1, Sofía Pérez-Del-Pulgar5, Swan Thung1, Jigjidsuren Chinburen8, Eric Letouzé9, Jessica Zucman-Rossi9, Andrew Uzilov4,10, Jaclyn Neely11, Xavier Forns5, Sasan Roayaie12, Daniela Sia1, Josep M Llovet1,2,13.   

Abstract

PURPOSE: Mongolia has the world's highest incidence of hepatocellular carcinoma (HCC), with ∼100 cases/100,000 inhabitants, although the reasons for this have not been thoroughly delineated. EXPERIMENTAL
DESIGN: We performed a molecular characterization of Mongolian (n = 192) compared with Western (n = 187) HCCs by RNA sequencing and whole-exome sequencing to unveil distinct genomic and transcriptomic features associated with environmental factors in this population.
RESULTS: Mongolian patients were younger, with higher female prevalence, and with predominantly HBV-HDV coinfection etiology. Mongolian HCCs presented significantly higher rates of protein-coding mutations (121 vs. 70 mutations per tumor in Western), and in specific driver HCC genes (i.e., APOB and TSC2). Four mutational signatures characterized Mongolian samples, one of which was novel (SBS Mongolia) and present in 25% of Mongolian HCC cases. This signature showed a distinct substitution profile with a high proportion of T>G substitutions and was significantly associated with a signature of exposure to the environmental agent dimethyl sulfate (71%), a 2A carcinogenic associated with coal combustion. Transcriptomic-based analysis delineated three molecular clusters, two not present in Western HCC; one with a highly inflamed profile and the other significantly associated with younger female patients.
CONCLUSIONS: Mongolian HCC has unique molecular traits with a high mutational burden and a novel mutational signature associated with genotoxic environmental factors present in this country. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35998012      PMCID: PMC7613712          DOI: 10.1158/1078-0432.CCR-22-0632

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   13.801


  43 in total

1.  Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.

Authors:  Milan J Sonneveld; Vincent Rijckborst; Stefan Zeuzem; E Jenny Heathcote; Krzysztof Simon; Hakan Senturk; Suzan D Pas; Bettina E Hansen; Harry L A Janssen
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

2.  Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.

Authors:  Melanie Schaper; Francisco Rodriguez-Frias; Rosendo Jardi; David Tabernero; Maria Homs; Gerardo Ruiz; Josep Quer; Rafael Esteban; Maria Buti
Journal:  J Hepatol       Date:  2010-03-05       Impact factor: 25.083

3.  International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

Authors:  Jessica L Petrick; Megan Braunlin; Mathieu Laversanne; Patricia C Valery; Freddie Bray; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2016-06-28       Impact factor: 7.396

4.  Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification.

Authors:  Sung-Min Ahn; Se Jin Jang; Ju Hyun Shim; Deokhoon Kim; Seung-Mo Hong; Chang Ohk Sung; Daehyun Baek; Farhan Haq; Adnan Ahmad Ansari; Sun Young Lee; Sung-Min Chun; Seongmin Choi; Hyun-Jeung Choi; Jongkyu Kim; Sukjun Kim; Shin Hwang; Young-Joo Lee; Jong-Eun Lee; Wang-Rim Jung; Hye Yoon Jang; Eunho Yang; Wing-Kin Sung; Nikki P Lee; Mao Mao; Charles Lee; Jessica Zucman-Rossi; Eunsil Yu; Han Chu Lee; Gu Kong
Journal:  Hepatology       Date:  2014-09-22       Impact factor: 17.425

5.  High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases.

Authors:  Bing-Fang Chen; Chun-Jen Liu; Guey-Mei Jow; Pei-Jer Chen; Jia-Horng Kao; Ding-Shinn Chen
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

7.  OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers.

Authors:  Claudia Arnedo-Pac; Loris Mularoni; Ferran Muiños; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Bioinformatics       Date:  2019-11-01       Impact factor: 6.937

8.  Exploring knowledge, attitudes, and practices related to alcohol in Mongolia: a national population-based survey.

Authors:  Alessandro R Demaio; Otgontuya Dugee; Maximillian de Courten; Ib C Bygbjerg; Palam Enkhtuya; Dan W Meyrowitsch
Journal:  BMC Public Health       Date:  2013-02-27       Impact factor: 3.295

9.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

10.  The genomic landscape of Mongolian hepatocellular carcinoma.

Authors:  Julián Candia; Enkhjargal Bayarsaikhan; Mayank Tandon; Anuradha Budhu; Marshonna Forgues; Lkhagva-Ochir Tovuu; Undarmaa Tudev; Justin Lack; Ann Chao; Jigjidsuren Chinburen; Xin Wei Wang
Journal:  Nat Commun       Date:  2020-09-01       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.